nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

Open Access 12.05.2017 | Original Article

A controlled comparison of the BacT/ALERT® 3D and VIRTUO™ microbial detection systems

verfasst von: H. Totty, M. Ullery, J. Spontak, J. Viray, M. Adamik, B. Katzin, W. M. Dunne Jr, P. Deol

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2017

Abstract

The performance of the next-generation BacT/ALERT® VIRTUO™ Microbial Detection System (VIRTUO™, bioMérieux Inc., Hazelwood, MO) was compared to the BacT/ALERT® 3D Microbial Detection System (3D, bioMérieux Inc., Durham, NC) using BacT/ALERT® FA Plus (FA Plus), BacT/ALERT® PF Plus (PF Plus), BacT/ALERT® FN Plus (FN Plus), BacT/ALERT® Standard Aerobic (SA), and BacT/ALERT® Standard Anaerobic (SN) blood culture bottles (bioMérieux Inc., Durham, NC). A seeded limit of detection (LoD) study was performed for each bottle type in both systems. The LoD studies demonstrated that both systems were capable of detecting organisms at nearly identical levels [<10 colony-forming units (CFU) per bottle], with no significant difference. Following LoD determination, a seeded study was performed to compare the time to detection (TTD) between the systems using a panel of clinically relevant microorganisms inoculated at or near the LoD with 0, 4, or 10 mL of healthy human blood. VIRTUO™ exhibited a faster TTD by an average of 3.5 h, as well as demonstrated a significantly improved detection rate of 99.9% compared to 98.8% with 3D (p-value <0.05).

ESM 1 (DOC 63 kb)

Electronic supplementary material

The online version of this article (doi:10.1007/s10096-017-2994-8) contains supplementary material, which is available to authorized users.

Introduction

Each year in the USA, there are approximately 200,000 documented bloodstream infections [1]. Delayed laboratory diagnosis of bacteremia or fungemia can lead to increased mortality [2]. Therefore, rapid detection of microorganisms in blood and sterile body fluids is essential for optimized patient care. The BacT/ALERT® VIRTUO™ Microbial Detection System is the next generation of BacT/ALERT® instrumentation with an improved user interface capable of providing automated processes that were previously performed manually. The VIRTUO™ system consists of an incubator, agitation mechanism, robotic apparatus for automated loading and unloading of bottles, and a tactile graphical user interface. The versatile and scalable design of VIRTUO™ allows for enhanced bottle capacity with a smaller footprint in the laboratory. Employing the same colorimetric technology used in previous generations of BacT/ALERT® instruments, VIRTUO™ measures the change in pH of the media associated with microbial growth and CO₂ production via a colorimetric sensor in each bottle and optically monitors the reflectance of the sensor over time [3]. The system stores and interprets these readings using algorithms embedded in the firmware and/or software. More importantly, VIRTUO™ uses a new algorithm designed to optimize test sensitivity and specificity, while significantly reducing the time to detection (TTD) of microbial growth when paired with BacT/ALERT® FA Plus, PF Plus, FN Plus, Standard Aerobic (SA), or Standard Anaerobic (SN) bottles.

The BacT/ALERT® bottles are each formulated to recover and detect a subset of clinically relevant microorganisms. SA culture bottles are intended for aerobic microorganisms, while the SN bottles contain media and atmospheric conditions designed for anaerobic microorganisms [4, 5]. FA Plus and PF Plus culture bottles contain antimicrobial neutralizing resins as well as media and atmospheric conditions suitable for aerobic and facultative microorganisms [6, 7]. PF Plus bottles recover and detect microorganisms when only a small volume of blood is available [16]. FN Plus culture bottles also employ antimicrobial neutralizing resins, while using media and atmosphere essential for anaerobes [8].

A series of seeded studies directly compared the instrumentation and growth-based detection algorithms of the 3D and VIRTUO™ systems. The limit of detection (LoD) was evaluated using a test set of clinically relevant organisms seeded into bottles to determine the lowest inoculum [colony-forming units (CFU) per bottle] in which a 95% detection rate is obtained. Once the LoD was established, a controlled seeded study was performed at/near the LoD for each test organism with different blood volumes to compare the detection rates and TTD between systems.

Materials and methods

Limit of detection

For each organism–inocula evaluated, 60 bottles were seeded. A single inoculum was prepared for each microorganism and tested in FA Plus, PF Plus, FN Plus, SA, and SN bottles (Table 1). BioBalls™ or colonies from solid media were serially diluted to achieve a target suspension of 10 CFU per mL. Bottles were inoculated with 0.5 mL of the target suspension. Plate counts were conducted for each inoculum before and after bottle inoculation. Thirty bottles were loaded into 3D and 30 were loaded into VIRTUO™. Once bottles flagged positive, they were promptly subcultured to confirm purity. Negative bottles remained in the instrument for 5 days until declared negative, at which time they were subcultured to verify the absence of microorganism.

Table 1

Limit of detection (LoD) test panel by bottle type

Bottle type	Microorganism	Strain
FA Plus and PF Plus	Candida albicans	ATCC 14053
	Enterococcus faecalis	NCTC 12697
	Escherichia coli	NCTC 12923
	Haemophilus influenzae ^a	ATCC 10211
	Pseudomonas aeruginosa	ATCC 9027
	Staphylococcus aureus	NCTC 10788
	Streptococcus pneumoniae	ATCC 6305
FN Plus	Bacteroides fragilis ^c	ATCC 25285
	Clostridium perfringens	NCTC 8789
	Enterococcus faecalis	NCTC 12697
	Escherichia coli	NCTC 12923
	Staphylococcus aureus	NCTC 10788
	Streptococcus pneumoniae	ATCC 6305
SA	Aspergillus brasiliensis	NCPF 2275
	Candida albicans	ATCC 14053
	Enterococcus faecalis	ATCC 12697
	Escherichia coli	NCTC 12923
	Haemophilus influenzae ^a	ATCC 10211
	Pseudomonas aeruginosa	ATCC 9027
	Staphylococcus aureus	NCTC 10788
	Streptococcus pneumoniae ^b	ATCC 6305
SN	Bacteroides fragilis	ATCC 25285
	Clostridium perfringens	NCTC 8789
	Enterococcus faecalis	NCTC 12697
	Escherichia coli	NCTC 12923
	Staphylococcus aureus	NCTC 10788
	Streptococcus pneumoniae ^b	ATCC 6305

^aSupplemented with 1 mL human blood

^bSupplemented with 1 mL human blood for SA and SN only

^cSupplemented with 4 mL human blood for FN Plus only

The LoD was defined for each organism/bottle/system as the lowest inocula that resulted in at least 95% of the bottles being declared positive. Based on a Poisson distribution, in a target inoculum of 3 CFU, approximately 5% of the bottles would not receive a single organism, 42% would receive less than 3 CFU, and 53% would receive 3 CFU or greater.

Comparison of detection systems

Human blood was collected from healthy donors in tubes containing 0.35% sodium polyanethol sulfonate (SPS) in 0.85% sodium chloride and pooled prior to testing [9]. Prior to inoculation, bottles were supplemented at three blood volumes: 0 mL, representing sterile body fluid; 4 mL, representing a pediatric blood sample volume; and 10 mL, representing an adult blood sample volume (Table 2). Uninoculated bottles containing 0, 4, or 10 mL blood served as negative controls. Both systems received nine seeded bottles at three blood volumes, for a total of 27 replicates per microorganism and bottle type.

Table 2

Instrument and algorithm comparison panel by bottle type

Bottle type	Organism	Bottles per organism in 3D	Bottles per organism in VIRTUO™	Blood volume (mL)
FA Plus, PF Plus, and SA	Abiotrophia defectiva	27	27	0^a, 4^b, 10^c
	Aggregatibacter actinomycetemcomitans ^d
	Aspergillus fumigatus
	Aspergillus brasiliensis
	Campylobacter jejuni ^e
	Candida albicans
	Candida glabrata
	Candida krusei
	Cardiobacterium hominis
	Corynebacterium jeikeium ^d
	Cryptococcus neoformans
	Eikenella corrodens ^d
	Enterobacter aerogenes
	Enterococcus faecalis
	Escherichia coli
	Haemophilus influenzae ^d
	Klebsiella pneumoniae
	Listeria monocytogenes
	Micrococcus luteus
	Neisseria meningitidis ^d
	Proteus vulgaris
	Pseudomonas aeruginosa
	Salmonella enterica
	Serratia marcescens
	Staphylococcus aureus
	Staphylococcus epidermidis
	Stenotrophomonas maltophilia
	Streptococcus agalactiae
	Streptococcus mitis
	Streptococcus pneumoniae
	Streptococcus pyogenes
FN Plus and SN	Bacteroides fragilis
	Bacteroides thetaiotaomicron
	Bacteroides vulgatus
	Clostridium perfringens
	Clostridium septicum
	Eggerthella lenta
	Enterococcus faecalis
	Escherichia coli
	Fusobacterium nucleatum
	Parvimonas micra
	Peptoniphilus asaccharolyticus
	Staphylococcus aureus
	Streptococcus pneumoniae
	Streptococcus pyogenes

^aReflects sterile body fluid sample

^bReflects pediatric patient blood volume

^cReflects adult patient blood volume

^dFastidious organisms not expected to grow in the absence of blood

^eMicroaerophilic organism not expected to grow in SA bottle type

Thirty-two aerobic microorganism and 14 anaerobic microorganisms were used to evaluate the performance of the detection systems. Each microorganism was serially diluted to a target inoculum of ≤ 30 CFU/bottle. Plate counts were performed on each inocula before and after each testing event to verify purity and appropriate microorganism density. Bottles were incubated until flagged positive or declared negative after 5 days. All inoculated negative bottles were examined for the presence of viable organisms by subculture. Two positive bottles from each test combination were randomly selected for subculture to verify purity of the inoculated bottles.

All possible differences between 3D and VIRTUO™ TTD were calculated for bottle type, organism, and fill volume using pairwise analysis. Only matched test bottles (bottle type, organism, and blood volume) for which data were available from both culture systems were included in the final comparison analysis. TTD detections were compared between each system at the level of bottle type, organism, and blood volume. Ratios were calculated from TTD results for each microorganism by dividing the TTD from VIRTUO™ by the TTD from 3D. A ratio less than 1 indicates an improvement in TTD on VIRTUO™. A ratio approximately equal to 1 indicates that the TTD on 3D and VIRTUO™ were equivalent. Detection rates between instrument types were compared using Fisher’s exact test.

Results

Limit of detection

A total of 479 seeded BacT/ALERT® bottles were tested in the 3D system. Of these, 473 (98.8%) were declared positive and confirmed by subculture. A total of 1616 seeded culture bottles were tested in the VIRTUO™ system, with 1605 (99.3%) declared positive. All negative bottles were determined to be true-negative results by terminal subculture. Both systems were capable of detecting less than CFU/bottle for all bottle types. There was no difference in the LoD of the VIRTUO™ system for different bottle types when compared to the established LoD of the 3D system (Supplemental Tables 1a–d).

Comparison of time to detection between systems

The VIRTUO™ algorithm provided an overall mean reduction in TTD of approximately 3.48 h (Table 3). FN Plus bottles exhibited the greatest TTD improvement, with an average decrease of 3.90 h. The SA bottle type had the least TTD improvement, with an average decrease of 3.14 h.

Table 3

Time to detection (TTD) and detection rates from BacT/ALERT® 3D and VIRTUO™ by bottle type and blood volume

Bottle type	Blood volume (mL)	3D		VIRTUO™		TTD difference (3D - VIRTUO™)
Bottle type	Blood volume (mL)	# (+)/#	Detection rate (%)	# (+)/#	Detection rate (%)	Mean TTD difference (h)	95% CI for mean TTD difference (h)
FA Plus	0	227/239	95.0	233/233	100.0*	3.62	(3.37, 3.86)
	4^**	271/272	99.6	275/275	100.0	3.94	(3.47, 4.41)
	10	273/278	98.2	279/279	100.0*	3.24	(2.96, 3.51)
	Combined	771/789	97.7	787/787	100.0*	3.59	(3.39, 3.80)
FN Plus	0	93/93	100.0	91/91	100.0	3.62	(3.14, 4.10)
	4	117/121	96.7	122/122	100.0^*	3.78	(3.27, 4.29)
	10	110/115	95.7	114/114	100.0*	4.28	(3.93, 4.64)
	Combined	320/329	97.3	327/327	100.0*	3.90	(3.64, 4.17)
SA	0	215/215	100.0	213/213	100.0	2.35	(2.13, 2.56)
	4	276/276	100.0	279/279	100.0	3.47	(3.33, 3.61)
	10	270/270	100.0	276/276	100.0	3.38	(3.14, 3.62)
	Combined	761/761	100.0	768/768	100.0	3.14	(3.02, 3.25)
SN	0	125/125	100.0	123/123	100.0	4.65	(4.46, 4.84)
	4	124/124	100.0	116/117	99.1	4.02	(3.76, 4.29)
	10	119/120	99.2	119/120	99.2	2.20	(1.58, 2.82)
	Combined	368/369	99.7	358/360	99.4	3.65	(3.42, 3.88)
Overall		2220/2248	98.8	2240/2242	99.9*	3.48	(3.38, 3.58)

*Significant difference between detection rates; Fisher’s exact test p-value <0.05; ^**represents PF Plus

Based on the comparison ratios (Table 4), all organisms had faster or equivalent TTD with VIRTUO™, except for Stenotrophomonas maltophilia, which generated slower TTD in FA Plus bottles (data not shown). Over half of the Gram-negative organisms tested had an average TTD of less than 24 h in the VIRTUO™ system, with an overall TTD ratio of 0.85. Overall, Gram-positive organisms demonstrated the greatest TTD improvement. Abiotrophia defectiva and Corynebacterium jeikeium exhibited the largest TTD reductions in VIRTUO™, with comparison ratios of 0.66 and 0.65, respectively (Table 4). Large decreases in TTD across both anaerobic bottle types were also observed in VIRTUO™ with Clostridium perfringens and Clostridium septicum (Table 4). Yeasts demonstrated smaller TTD improvements with VIRTUO™. Although the test panel for moulds was limited, the TTD of both Aspergillus species benefited from the VIRTUO™ detection algorithm (Table 4).

Table 4

Overall TTD comparisons between BacT/ALERT® 3D and VIRTUO™ by organism

Group	Organism	3D		VIRTUO™		Comparison ratio (VIRTUO™ TTD/3D TTD)
Group	Organism	Mean TTD (h)	Recovery rate (%)	Mean TTD (h)	Recovery rate (%)	Comparison ratio (VIRTUO™ TTD/3D TTD)
Gram-positive	Abiotrophia defectiva	25.7	100.0	17.0	100.0	0.66
	Clostridium perfringens	12.1	100.0	9.1	100.0	0.76
	Clostridium septicum	16.6	100.0	12.3	100.0	0.74
	Corynebacterium jeikeium	50.5	100.0	32.8	100.0	0.65
	Eggerthella lenta	35.3	94.4	34.7	96.2	0.98
	Enterococcus faecalis	14.2	100.0	11.3	100.0	0.80
	Listeria monocytogenes	21.7	100.0	20.2	100.0	0.93
	Micrococcus luteus	35.1	100.0	32.5	100.0	0.93
	Parvimonas micra	47.0	100.0	41.0	100.0	0.87
	Peptoniphilus asaccharolyticus	51.3	100.0	46.9	100.0	0.91
	Staphylococcus aureus	16.1	100.0	13.1	100.0	0.81
	Staphylococcus epidermidis	19.8	100.0	17.1	100.0	0.86
	Streptococcus agalactiae	15.1	100.0	11.6	100.0	0.77
	Streptococcus mitis	13.2	100.0	10.2	100.0	0.77
	Streptococcus pneumoniae	17.1	100.0	14.5	100.0	0.85
	Streptococcus pyogenes	15.3	100.0	12.6	100.0	0.82
Gram-negative	Aggregatibacter actinomycetemcomitans	46.5	100.0	43.4	100.0	0.93
	Bacteroides fragilis	34.7	100.0	32.4	100.0	0.94
	Bacteroides thetaiotaomicron	42.9	100.0	36.7	100.0	0.86
	Bacteroides vulgatus	43.3	100.0	40.7	100.0	0.94
	Campylobacter jejuni	46.1	100.0	41.6	100.0	0.90
	Cardiobacterium hominis	54.9	80.0	47.9	100.0	0.87
	Eikenella corrodens	26.2	100.0	22.5	100.0	0.86
	Enterobacter aerogenes	12.9	100.0	10.7	100.0	0.83
	Escherichia coli	11.4	100.0	9.0	100.0	0.79
	Fusobacterium nucleatum	53.9	84.4	43.7	100.0	0.81
	Haemophilus influenzae	20.0	100.0	16.9	100.0	0.85
	Klebsiella pneumoniae	12.2	100.0	9.7	100.0	0.80
	Neisseria meningitidis	22.3	100.0	19.3	100.0	0.86
	Proteus vulgaris	13.8	100.0	11.4	100.0	0.82
	Pseudomonas aeruginosa	17.6	100.0	14.3	100.0	0.81
	Salmonella enterica	13.6	100.0	11.1	100.0	0.82
	Serratia marcescens	15.1	100.0	11.3	100.0	0.75
	Stenotrophomonas maltophilia	29.4	100.0	36.6	100.0	1.25
Mould	Aspergillus fumigatus	34.9	100.0	30.2	100.0	0.87
Mould	Aspergillus brasiliensis	58.4	83.0	46.3	100.0	0.79
Yeast	Candida albicans	27.3	100.0	26.1	100.0	0.95
	Candida glabrata	51.9	100.0	44.3	100.0	0.85
	Candida krusei	21.9	100.0	19.8	100.0	0.90
	Cryptococcus neoformans	63.2	100.0	63.2	100.0	1.00

Comparison of detection rates between systems

In some instances, bottles inoculated at or near the LoD remained negative, likely due to the non-uniform distribution (Poisson distribution) of the inoculum. Only matched test bottles (bottle type, organism, and blood volume) for which data were available from both detection systems were included in the final comparison analysis.

A total of 2242 inoculated culture bottles were tested in the VIRTUO™ system, of which 2240 (99.9%) were declared positive. A total of 2248 inoculated bottles tested in the 3D system were available for comparison to VIRTUO™, of which 2220 (98.8%) were declared positive (Table 3).

For individual bottle types, only the rates of detection observed for SN bottles containing blood were not significantly different between systems (p > 0.05; Table 3). All other bottle types tested demonstrated a detection rate in the VIRTUO™ greater than or equal to the detection rate of 3D. All seeded SA, FA Plus, and FN Plus bottles were declared positive in the VIRTUO™ system (Table 4). Furthermore, FN Plus bottles in the 3D system exhibited decreased detection rates as blood volume increased, resulting in seven false-negative results for Fusobacterium nucleatum (Table 3). False-negative results were also observed in FA Plus bottles seeded with Cardiobacterium hominis and Aspergillus brasiliensis in the 3D system.

Discussion

While testing at lower inoculum levels may delay TTD, comparing the detection systems at or near the LoD provides a more stringent evaluation compared to clinical samples. The data presented showed no difference in the LoD between 3D and VIRTUO™ for the panel of microorganisms tested. Even at low inoculum levels, 55% of the organisms evaluated in this study had an average TTD of less than 24 h in VIRTUO™. Further, our data demonstrates that the VIRTUO™ system provided a significantly improved rate of detection and faster TTD compared to the 3D (p < 0.05).

Overall, VIRTUO™ exhibited an improved detection rate of 99.9% compared to the 98.8% detection rate of 3D, with an average decrease in TTD of 3.48 h. FN Plus bottles had the most noticeable TTD improvement, with an average reduction of 3.90 h. Another seeded study reported significantly faster TTD with VIRTUO™ compared to 3D for several bacterial species in FA Plus and FN Plus bottles, with a median reduction of 2.8 h [10]. Additionally, the TTD for Candida glabrata in FA Plus bottles was reduced from a median of 65 h on 3D to 54 h on VIRTUO™ [10]. Previous studies demonstrate faster TTD for antibiotic-free samples and coagulase-negative staphylococci with BacT/ALERT® FA Plus and FN Plus bottles compared to BD BACTEC™ culture bottles [11‐13]. The improved detection algorithm of the VIRTUO™ system could further enhance this advantage in cases where blood cultures are collected from patients receiving concurrent antimicrobial therapy [6, 8, 10].

Gram-positive organisms had the greatest reduction in TTD with VIRTUO™. In addition, VIRTUO™ improved the TTD for Fusobacterium nucleatum by an average of 1.8 days (31 to 57 h, depending on bottle type). Earlier case studies report that the mean number of days required to recover this organism from blood culture in the BACTEC™ system (BACTEC 9120, BD Diagnostic Systems) was 2.6 days (range 35–87 h) [12]. Additionally, the VIRTUO™ algorithm detected 100% of F. nucleatum in FN Plus bottles, as well as 100% of Aspergillus brasiliensis and Cardiobacterium hominis in FA Plus bottles, whereas for these same combinations, the 3D system generated a few false-negative results. Although our panel evaluated a limited subset of yeast and moulds, a high number of Aspergillus false-negatives have been observed using various blood culture systems, including the BACTEC™ and 3D systems [14]. In some instances, organisms may be encountered that grow in the culture bottle but do not produce sufficient CO₂ to signal positive [4‐8]. A previous report indicated that C. hominis generally produces small incremental changes to the growth indices in automated blood culture systems after 3–5 days and recommended incubation for at least 14 days before cultures are presumed negative [15, 16]. The improved algorithm of VIRTUO™ is capable of detecting these minute changes, reducing false-negative results, and allowing for an overall reduction in C. hominis TTD from 54.9 h in 3D to 47.9 h.

Automated blood culture systems provide improved detection of bacteremia and fungemia and, as a result, have become a staple in the diagnostic clinical microbiology laboratory. Our studies compared the instrumentation and growth-based algorithms of the 3D and VIRTUO™ systems using a panel of compatible blood culture bottles seeded with tightly controlled inoculum levels at/near the LoD and at multiple blood volumes. The VIRTUO™ algorithm improved positive blood culture TTD while reducing false-negative results when directly compared to the current 3D system. Further comparison studies performed with patient samples in a clinical setting are needed to validate the improved performance of VIRTUO™.

Compliance with ethical standards

Conflict of interest

All authors are employees of bioMérieux, Inc., manufacturer of the BacT/ALERT® 3D, BacT/ALERT® VIRTUO™, and BacT/ALERT® blood culture bottles used in this manuscript.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt testen ¹

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt testen ²

Electronic supplementary material

ESM 1 (DOC 63 kb)

Magadia RR, Weinstein MP (2001) Laboratory diagnosis of bacteremia and fungemia. Infect Dis Clin North Am 15:1009–1024CrossRefPubMed

Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596CrossRefPubMed

BacT/ALERT® VIRTUO™ Microbial Detection System User Manual (2014-06) 414998-EN

BacT/ALERT® SA [package insert] (2010) bioMérieux, Inc., Durham, NC

BacT/ALERT® SN [package insert] (2011) bioMérieux, Inc., Durham, NC

BacT/ALERT® FA Plus [package insert] (2011) bioMérieux, Inc., Durham, NC

BacT/ALERT® PF Plus [package insert] (2016) bioMérieux, Inc., Durham, NC

BacT/ALERT® FN Plus [package insert] (2011) bioMérieux, Inc., Durham, NC

Clinical and Laboratory Standards Institute (CLSI) (2007) Principles and procedures for blood cultures; approved guideline. CLSI document M47-A. CLSI, Wayne

10.

Altun O, Almuhayawi M, Lüthje P, Taha R, Ullberg M, Özenci V (2016) Controlled evaluation of the new BacT/Alert Virtuo blood culture system for detection and time to detection of bacteria and yeasts. J Clin Microbiol 54:1148–1151CrossRefPubMedPubMedCentral

11.

Kirn TJ, Mirrett S, Reller LB, Weinstein MP (2014) Controlled clinical comparison of BacT/Alert FA Plus and FN Plus blood culture media with BacT/alert FA and FN blood culture media. J Clin Microbiol 52:839–843CrossRefPubMedPubMedCentral

12.

Terhes G, Piukovics K, Urbán E, Nagy E (2011) Four cases of bacteraemia caused by Fusobacterium nucleatum in febrile, neutropenic patients. J Med Microbiol 60:1046–1049CrossRefPubMed

13.

Fiori B, D’Inzeo T, Di Florio V, De Maio F, De Angelis G, Giaquinto A, Campana L, Tanzarella E, Tumbarello M, Antonelli M, Sanguinetti M, Spanu T (2014) Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and BACTEC Plus systems. J Clin Microbiol 52:3558–3567

14.

Rosa C, Araujo R, Rodrigues AG, Pinto-de-Sousa MI, Pina-Vaz C (2011) Detection of Aspergillus species in BACTEC blood cultures. J Med Microbiol 60:1467–1471CrossRefPubMed

15.

Lu PL, Hsueh PR, Hung CC, Teng LJ, Jang TN, Luh KT (2000) Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. J Clin Microbiol 38:2015–2017PubMedPubMedCentral

16.

Manso E, Strusi P, Massacci C, Ferrini L (1987) Endocarditis due to Cardiobacterium hominis. Boll Ist Sieroter Milan 66:489–490PubMed

Titel: A controlled comparison of the BacT/ALERT® 3D and VIRTUO™ microbial detection systems
verfasst von: H. Totty
M. Ullery
J. Spontak
J. Viray
M. Adamik
B. Katzin
W. M. Dunne Jr
P. Deol
Publikationsdatum: 12.05.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-017-2994-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

15.04.2024 | Inkretinmimetika | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

A controlled comparison of the BacT/ALERT® 3D and VIRTUO™ microbial detection systems

Abstract

Electronic supplementary material

Introduction

Materials and methods

Limit of detection

Comparison of detection systems

Results

Limit of detection

Comparison of time to detection between systems

Comparison of detection rates between systems

Discussion

Compliance with ethical standards

Conflict of interest

Unsere Produktempfehlungen

e.Med Interdisziplinär

e.Med Innere Medizin

Electronic supplementary material

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Fast jeder zehnte Magen bei Endoskopie noch nicht entleert

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Blutdrucksenkung per Spritze additiv zur Standardtherapie wirksam

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Innere Medizin

Springer Medizin

Abstract

Electronic supplementary material

Introduction

Materials and methods

Limit of detection

Comparison of detection systems

Results

Limit of detection

Comparison of time to detection between systems

Comparison of detection rates between systems

Discussion

Compliance with ethical standards

Conflict of interest

Unsere Produktempfehlungen

e.Med Interdisziplinär

e.Med Innere Medizin

Electronic supplementary material

Weitere Artikel der Ausgabe 10/2017

Importance of pre-enrichment for detection of third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB) from rectal swabs

Household aggregation of Staphylococcus aureus by clonal complex and methicillin resistance profiles in Starr County, Texas

Dissemination of bla OXA-370 gene among several Enterobacteriaceae species in Brazil

Adherence to clinical practice guidelines for the management of Clostridium difficile infection in Japan: a multicenter retrospective study

Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran

Emergence of Clostridium difficile tcdC variant 078 in Marseille, France

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Fast jeder zehnte Magen bei Endoskopie noch nicht entleert

Verbesserung der HDL-Funktion als Lipidtherapie floppt in Mega-Studie

Blutdrucksenkung per Spritze additiv zur Standardtherapie wirksam

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Innere Medizin